Form 4 for BLTE BELITE BIO, INC
Accepted 2026-04-23 16:23:00 ET · period of report 2026-04-21 · accession 0001193125-26-173778 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 16:23 | 2026-04-21 | BLTE | Lin Yu-Hsin | CEO, Dir | J - Other | $0.00 | +10.0K | 182.9K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Share | 2026-04-21 | J | A | 10,000 | $0.00 | 182,949 | D | — | — | (F1) On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of certain performance criteria. Such performance criteria was met on 04/21/2026, resulting in vesting of the RSUs as to 10,000 ordinary shares. (F1) On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of certain performance criteria. Such performance criteria was met on 04/21/2026, resulting in vesting of the RSUs as to 10,000 ordinary shares. (F1) On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of certain performance criteria. Such performance criteria was met on 04/21/2026, resulting in vesting of the RSUs as to 10,000 ordinary shares. |